Your browser doesn't support javascript.
loading
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma.
Sajisevi, Mirabelle; Nguyen, Kenny; Callas, Peter; Holcomb, Andrew J; Vural, Emre; Davis, Kyle P; Thomas, Carissa M; Plonowska-Hirschfeld, Karolina A; Stein, John S; Eskander, Antoine; Kakarala, Kiran; Enepekides, Danny J; Hier, Michael P; Ryan, William R; Asarkar, Ameya A; Aulet, Ricardo; Bell, Rebecca K; Blasco, Michael A; Bowmaster, Vanessa B; Burruss, Clayton P; Chung, Jeffson; Chan, Kimberly; Chang, Brent A; Coffey, Charles S; Cognetti, David M; Cooper, Dylan J; Cordero, Joehassin; Donovan, John; Du, Yue Jennifer; Dundar, Yusuf; Dedivitis, Rogerio A; Edwards, Heather A; Erovic, Boban M; Feinberg, Philip A; Garvey, Emily A; Goldstein, David P; Goodman, Joseph F; Goulart, Rafael N; Goyal, Neerav; Grasl, Stefan; Giurintano, Jonathan P; Gupta, Nikita; Habib, Andy M; Hackman, Trevor G; Hara, Jared H; Henson, Christina; Hinni, Michael L; Hua, Nadia; Johnson-Obaseki, Stephanie; Juloori, Aditya.
Afiliação
  • Sajisevi M; Division of Otolaryngology, University of Vermont Medical Center, Burlington.
  • Nguyen K; Robert Larner College of Medicine, University of Vermont, Burlington.
  • Callas P; Robert Larner College of Medicine, University of Vermont, Burlington.
  • Holcomb AJ; Department of Head & Neck Surgical Oncology, Estabrook Cancer Center, Nebraska Methodist Hospital, Omaha.
  • Vural E; Department of Otolaryngology, University of Arkansas for Medical Sciences, Little Rock.
  • Davis KP; Department of Otolaryngology, St Louis University School of Medicine, St Louis, Missouri.
  • Thomas CM; Department of Otolaryngology, University of Alabama at Birmingham.
  • Plonowska-Hirschfeld KA; Department of Otolaryngology, University of California, San Francisco.
  • Stein JS; Department of Otolaryngology, University of Alabama at Birmingham.
  • Eskander A; Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Sunnybrook Health Sciences Centre and Michael Garron Hospital, Toronto, Ontario, Canada.
  • Kakarala K; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Enepekides DJ; Department of Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City.
  • Hier MP; Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Sunnybrook Health Sciences Centre and Michael Garron Hospital, Toronto, Ontario, Canada.
  • Ryan WR; Otolaryngology-Head and Neck Surgery, Jewish General Hospital, Montreal, Québec, Canada.
  • Aulet R; Department of Otolaryngology/Head & Neck Surgery, Ochsner-LSU Health, Shreveport, Louisiana.
  • Bell RK; Department of Otolaryngology, UMass Memorial Medical Center, Worcester, Massachusetts.
  • Blasco MA; Geisel School of Medicine at Dartmouth, Section of Otolaryngology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
  • Bowmaster VB; Department of Otolaryngology, Donald and Barbara Zucker School of Medicine/Northwell, Northwell Health Cancer Institute, New York, New York.
  • Burruss CP; University of Nebraska College of Medicine, Omaha.
  • Chung J; University of Kentucky, Department of Otolaryngology-Head and Neck Surgery, Lexington.
  • Chan K; Department of Otolaryngology-Head & Neck Surgery, West Virginia University, Morgantown.
  • Chang BA; Department of Otolaryngology Head and Neck Surgery, Penn State College of Medicine, Hershey, Pennsylvania.
  • Coffey CS; Department of Otolaryngology-Head & Neck Surgery, Mayo Clinic Arizona, Phoenix.
  • Cognetti DM; Department of Otolaryngology/Head & Neck Surgery, University of California San Diego School of Medicine.
  • Cooper DJ; Department of Otolaryngology-Head & Neck Surgery, Sidney Kimmel Medical College/Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Cordero J; Department of Otolaryngology, Donald and Barbara Zucker School of Medicine/Northwell, Northwell Health Cancer Institute, New York, New York.
  • Donovan J; Department of Otolaryngology and Head & Neck Surgery, Texas Tech University - Health Sciences Center, Lubbock.
  • Du YJ; Salem Hospital, Salem, Oregon.
  • Dundar Y; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Dedivitis RA; Department of Otolaryngology and Head & Neck Surgery, Texas Tech University - Health Sciences Center, Lubbock.
  • Edwards HA; Department of Head and Neck Surgery, University of São Paulo School of Medicine, Ribeirão Preto, São Paulo, Brazil.
  • Erovic BM; Department of Otolaryngology, Boston Medical Center, Boston, Massachusetts.
  • Feinberg PA; Institute of Head and Neck Diseases, Evangelical Hospital Vienna, Vienna, Austria.
  • Garvey EA; Medical Scientist Training Program, UMass Chan Medical School, Worcester, Massachusetts.
  • Goldstein DP; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • Goodman JF; Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Goulart RN; Division of Otolaryngology-Head and Neck Surgery, George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Goyal N; Hospital Governador Celso Ramos, Florianopolis, Brazil.
  • Grasl S; Department of Otolaryngology Head and Neck Surgery, Penn State College of Medicine, Hershey, Pennsylvania.
  • Giurintano JP; Department of Otorhinolaryngology-Head and Neck Surgery, Medical University of Vienna, Vienna, Austria.
  • Gupta N; Department of Otolaryngology, Georgetown, Washington, DC.
  • Habib AM; University of Kentucky, Department of Otolaryngology-Head and Neck Surgery, Lexington.
  • Hackman TG; Department of Otolaryngology, Georgetown, Washington, DC.
  • Hara JH; Department of Otolaryngology/Head & Neck Surgery, The University of North Carolina at Chapel Hill.
  • Henson C; Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.
  • Hinni ML; Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City.
  • Hua N; Department of Otolaryngology-Head & Neck Surgery, Mayo Clinic Arizona, Phoenix.
  • Johnson-Obaseki S; Department of Otolaryngology-Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada.
  • Juloori A; Department of Otolaryngology-Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada.
JAMA Otolaryngol Head Neck Surg ; 150(2): 107-116, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-38095911
ABSTRACT
Importance Postoperative radiation therapy for close surgical margins in low- to intermediate-grade salivary carcinomas lacks multi-institutional supportive evidence.

Objective:

To evaluate the oncologic outcomes for low- and intermediate-grade salivary carcinomas with close and positive margins. Design, Setting, and

Participants:

The American Head and Neck Society Salivary Gland Section conducted a retrospective cohort study from 2010 to 2019 at 41 centers. Margins were classified as R0 (negative), R1 (microscopically positive), or R2 (macroscopically positive). R0 margins were subclassified into clear (>1 mm) or close (≤1 mm). Data analysis was performed from June to October 2023. Main Outcomes and

Measures:

Main outcomes were risk factors for local recurrence.

Results:

A total of 865 patients (median [IQR] age at surgery, 56 [43-66] years; 553 female individuals [64%] and 312 male individuals [36%]) were included. Of these, 801 (93%) had parotid carcinoma and 64 (7%) had submandibular gland carcinoma, and 748 (86%) had low-grade tumors and 117 (14%) had intermediate-grade tumors, with the following surgical margins R0 in 673 (78%), R1 in 168 (19%), and R2 in 24 (3%). Close margins were found in 395 of 499 patients with R0 margins (79%), for whom margin distances were measured. A total of 305 patients (35%) underwent postoperative radiation therapy. Of all 865 patients, 35 (4%) had local recurrence with a median (IQR) follow-up of 35.3 (13.9-59.1) months. In patients with close margins as the sole risk factor for recurrence, the local recurrence rates were similar between those who underwent postoperative radiation therapy (0 of 46) or observation (4 of 165 [2%]). Patients with clear margins (n = 104) had no recurrences. The local recurrence rate in patients with R1 or R2 margins was better in those irradiated (2 of 128 [2%]) compared to observed (13 of 64 [20%]) (hazard ratio [HR], 0.05; 95% CI, 0.01-0.24). Multivariable analysis for local recurrence found the following independent factors age at diagnosis (HR for a 10-year increase in age, 1.33; 95% CI, 1.06-1.67), R1 vs R0 (HR, 5.21; 95% CI, 2.58-10.54), lymphovascular invasion (HR, 4.47; 95% CI, 1.43-13.99), and postoperative radiation therapy (HR, 0.10; 95% CI, 0.04-0.29). The 3-year local recurrence-free survivals for the study population were 96% vs 97% in the close margin group. Conclusions and Relevance In this cohort study of patients with low- and intermediate-grade major salivary gland carcinoma, postoperative radiation therapy for positive margins was associated with decreased risk of local recurrence. In isolation from other risk factors for local recurrence, select patients with close surgical margins (≤1 mm) may safely be considered for observation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Salivares / Carcinoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Salivares / Carcinoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article